Skip to main content
. 2022 Feb 20;27(4):1426. doi: 10.3390/molecules27041426

Figure 7.

Figure 7

The interaction of the 79 proteins that were enhanced in their expression in a comparable way to late and total apoptosis levels and those that are predicted to associate with anticancer drugs (e.g., doxorubicin, oxaliplatin, 5-fluorouracil, and capecitabine) or apoptotic proteins (e.g., caspase 3 and caspase 9) using the STITCH version 5.0 software. The dashed circles indicate the filtered proteins from the proteomics dataset that interact with anticancer drugs and apoptotic proteins.